Biotricity is trading 12% down at $0.06; no clear catalyst has been identified.
- The live price context shows the decline at 9:34 a.m. ET on October 2, 2026.
- Biotricity’s news-release archive has no company-specific announcement dated October 2; its newest listed release is from February 11, 2026.
- U.S. stock futures were rising ahead of the jobs report, but available evidence does not establish a market-wide cause for the drop.